Quantbot Technologies LP Rhythm Pharmaceuticals, Inc. Transaction History

Quantbot Technologies LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$39.12 - $52.44 $172,128 - $230,736	-4,400 Reduced 55.0%	3,600 $155,000
Q4 2023 Feb 14, 2024	BUY	$21.39 - $49.64 $171,120 - $397,120	8,000 New	8,000 $367,000
Q2 2022 Aug 09, 2022	SELL	$3.12 - $12.25 $7,918 - $31,090	-2,538 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$6.13 - $12.24 $15,557 - $31,065	2,538 New	2,538 $29,000
Q1 2020 May 13, 2020	SELL	$13.16 - $22.9 $19,253 - $33,502	-1,463 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$19.53 - $25.5 $28,572 - $37,306	1,463 New	1,463 $33,000
Q3 2018 Nov 13, 2018	SELL	$26.99 - $35.85 $130,253 - $173,012	-4,826 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$17.02 - $35.2 $82,138 - $169,875	4,826 New	4,826 $150,000

192

67.3M

834K

78.6K

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.13B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.